Results
|
781.
|
|
|
782.
|
|
|
783.
|
|
|
784.
|
Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitors. [electronic resource] by
- Zimmermann, Kurt
- Wittman, Mark D
- Saulnier, Mark G
- Velaparthi, Upender
- Langley, David R
- Sang, Xiaopeng
- Frennesson, David
- Carboni, Joan
- Li, Aixin
- Greer, Ann
- Gottardis, Marco
- Attar, Ricardo M
- Yang, Zheng
- Balimane, Praveen
- Discenza, Lorell N
- Vyas, Dolatrai
Producer: 20081117
In:
Bioorganic & medicinal chemistry letters vol. 18
Availability: No items available.
|
|
785.
|
|
|
786.
|
A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin. [electronic resource] by
- Grosso, Federica
- D'Incalci, Maurizio
- Cartoafa, Mirela
- Nieto, Antonio
- Fernández-Teruel, Carlos
- Alfaro, Vicente
- Lardelli, Pilar
- Roy, Elena
- Gómez, Javier
- Kahatt, Carmen
- Soto-Matos, Arturo
- Judson, Ian
Producer: 20120803
In:
Cancer chemotherapy and pharmacology vol. 69
Availability: No items available.
|
|
787.
|
|
|
788.
|
|
|
789.
|
|
|
790.
|
|
|
791.
|
|
|
792.
|
|
|
793.
|
|
|
794.
|
|
|
795.
|
|
|
796.
|
|
|
797.
|
|
|
798.
|
|
|
799.
|
|
|
800.
|
|